6月17日，爱德华兹盘中上涨3.51%，报89.31美元/股，成交额2.57亿美元。
消息面上，美国医疗保险和医疗补助服务中心（CMS）发布了关于经导管主动脉瓣置换术（TAVR）的国家覆盖决定（NCD）提议决策备忘录，预计将扩大TAVR在无症状主动脉瓣狭窄患者中的适用覆盖范围。加拿大皇家银行此前指出，该备忘录是爱德华兹的重要催化剂，其医师调研显示覆盖范围变更可推动全国手术量增长约5%，单操作员模式转变对手术效率提升最为显著，同时伴随手术场所扩展。结合美国心脏病学会/美国心脏协会指南更新，市场预期TAVR增长将加速。
爱德华兹所在的医疗保健设备行业中，雅培涨1.07%，美敦力涨0.91%，史赛克涨0.43%，直觉外科公司涨0.14%，波士顿科学跌0.4%。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.